OakChart

U.S. Physical Therapy Inc

USPHHealthcare·Medical Care Facilities·USA·Small·NYSE·Nov 11 • 12:41 PM ET

100.14+0.90 (0.91%)
2026-11-11 18:41 CET
Market cap
1,481.50 USD m
Revenue, TTM
837.63 USD m
Net income, TTM
-20.22 USD m
Free cash flow, TTM
70.46 USD m
EPS diluted, TTM
-1.35
P/E
-
Compare

Price

USPH against its 20, 50 and 200-day averages
2050200miss
60.0070.0080.0090.00100.00248K496KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26USPHclose 100.1420-day 89.7350-day 85.42200-day 77.09100.1452w low

1.0% under the 52-week high of 101.18 on 6 Nov 2026. 52-week low 58.19 on 8 May 2026. Last 15 sessions, 20.1% high to low

Profile

USPH
52-week range, 98% of the way up
58.19101.18

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the Physical Therapy Operations and Industrial Injury Prevention Services segments. The Physical Therapy Operations segment consists of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The Industrial Injury Prevention Services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The company was founded in 1990 and is headquartered in Houston, TX.

IndexRUT
Employees7294
IPOMay 28, 1992
Beta1.10
ATR, 14d3.28
Rel volume0.49
Short float7.77%
Insider own2.57%
Inst own111.60%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.49B
Enterprise Value2.23B
Income-20.22M
Sales837.63M
Book/sh28.76
Cash/sh2.56
Dividend Est.1.84 (1.84%)
Dividend TTM1.83 (1.83%)
Dividend Ex-DateNov 16, 2026
Dividend Gr. 3/5Y3.15% 41.26%
Payout126.62%
Employees7294
IPOMay 28, 1992

Ratios

P/E-
Forward P/E29.84
PEG2.58
P/S1.78
P/B3.48
P/C39.10
P/FCF21.22
EV/EBITDA20.64
EV/Sales2.67
Quick Ratio1.42
Current Ratio1.42
Debt/Eq0.98
LT Debt/Eq0.86
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.35
EPS next Y3.36
EPS next Q0.88
EPS this Y9.20%
EPS next Y16.84%
EPS next 5Y11.58%
EPS past 3/5Y-14.24% -10.50%
Sales past 3/5Y12.19% 13.05%
EPS Y/Y TTM-156.70%
Sales Y/Y TTM10.40%
EPS Q/Q-318.45%
Sales Q/Q12.90%
EarningsNov 04 AMC
EPS/Sales Surpr.5.86% 3.76%

Ownership

Insider Own2.57%
Insider Trans0.21%
Inst Own111.60%
Inst Trans3.94%
ROA-1.62%
ROE-4.33%
ROIC-2.53%
Gross Margin17.58%
Oper. Margin10.20%
Profit Margin-2.41%
SMA2011.60%
SMA5017.23%
SMA20029.91%
Trades-

Technical

Shs Outstand14.93M
Shs Float14.54M
Short Float7.77%
Short Ratio6.23
Short Interest1.13M
52W High101.18 -1.03%
52W Low58.19 72.09%
Volatility4.32% 3.56%
ATR (14)3.28
RSI (14)76.03
Beta1.10
Rel Volume0.49
Avg Volume181.23K
Volume45,751

Performance

Perf Week12.29%
Perf Month17.21%
Perf Quarter21.00%
Perf Half Y66.51%
Perf YTD28.24%
Perf Year34.61%
Perf 3Y21.57%
Perf 5Y-1.85%
Perf 10Y66.90%
Recom1.29
Target Price106.17
Prev Close99.24
Price100.14
Change %0.91%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
May 13, 2026ReiteratedBBarrington ResearchOutperform$103 → $90-10.1%
Mar 10, 2026ResumedJJefferiesBuy$102+1.9%
Sep 18, 2025ResumedJJP MorganOverweight$110+9.8%
Dec 16, 2024UpgradeBBofA SecuritiesNeutral → Buy$100 → $115+14.8%
Dec 16, 2024InitiatedJJMP SecuritiesMkt Outperform$113+12.8%
Oct 07, 2024DowngradeBBofA SecuritiesBuy → Neutral$114 → $90-10.1%
Sep 22, 2023InitiatedJJP MorganOverweight$108+7.8%
Jun 30, 2023InitiatedBBofA SecuritiesBuy$138+37.8%
Dec 14, 2021UpgradeCCJS SecuritiesMarket Perform → Market Outperform$120+19.8%
Aug 06, 2021ReiteratedBBarrington ResearchOutperform$130 → $139+38.8%

Peers

Mkt cap
TickerCompanyMkt cap
CONConcentra Group Holdings Parent Inc5.43B
EHCEncompass Health Corp13.88B
SGRYSurgery Partners Inc3.47B
JYNTJoint Corp91.45M
LFSTLifeStance Health Group Inc5.43B
PNTGPennant Group Inc1.29B
HNGEHinge Health Inc9.58B
MDPediatrix Medical Group Inc2.41B
ENSGEnsign Group Inc10.79B
PRVAPrivia Health Group Inc3.06B

Insider trading

12 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Minan Peter FrancisDirectorSep 11 '26Buy79.0054163,217Sep 14 04:17 PM
Minan Peter FrancisDirectorJun 12 '26Buy66.501583,212Sep 14 04:17 PM
Minan Peter FrancisDirectorJun 08 '26Buy63.1449231,0652,923Jun 10 06:36 PM
Minan Peter FrancisDirectorJun 09 '26Buy61.5028817,7123,211Jun 10 06:36 PM
REEVE GRAHAM D.COOMar 11 '26Sale78.8666252,20530,078Mar 12 04:41 PM
Graham ReeveaffiliateMar 11 '26Proposed Sale78.761,964154,688Mar 11 02:31 PM
Binstein RichardEVP Gen'l Counsel & SecretaryMar 06 '26Sale81.643,000244,92024,867Mar 09 04:28 PM
Graham ReeveCOOMar 06 '26Proposed Sale82.241,808148,687Mar 06 04:28 PM
Richard BinsteinAffilitateMar 06 '26Proposed Sale81.643,000244,905Mar 06 12:40 PM
REEVE GRAHAM D.COONov 24 '25Sale71.0174352,76020,740Nov 25 04:08 PM
Gilmartin Kathleen ADirectorNov 20 '25Buy69.004,000276,00024,786Nov 24 04:09 PM
Graham D. ReeveAffiliateNov 21 '25Proposed Sale71.0174352,762Nov 24 03:46 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
SMIGBahl & Gaynor Small/Mid Cap Income Growth ETFAUM: 1.50B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFATU.S. Targeted Value Portfolio-ETF Class Shares-
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B

News

latest 14 of 206
  • U.S. Physical Therapy Beats As Hospital Affiliations Drive Growth Acceleration, But Unchanged Guidance And Rising Costs Keep Investors Wary (Earnings Whispers) +8.99%
  • U.S. Physical Therapy: Q3 Earnings Snapshot (Associated Press) +5.24%
  • USPH Reports Third Quarter 2026 Results, Record High Visits and Revenue Per Visit (Business Wire)
  • U.S. Physical Therapy Must Prove Its Second-Quarter Margin Squeeze Was Temporary (Earnings Whispers)
  • U.S. Physical Therapy, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call Dates (Business Wire)
  • Loading…
  • U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis (Business Wire)
  • U.S. Physical Therapy Presented at the 17th Annual Midwest Ideas Conference (Business Wire)
  • U.S. Physical Therapy Announces CFO (Business Wire)
  • US Physical Therapy Inc (USPH) (Q2 2026) Earnings Call Highlights: Record Visits and Raised ... (GuruFocus.com)
  • U.S. Physical Therapy: Q2 Earnings Snapshot (Associated Press)
  • USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance (Business Wire)
  • U.S. Physical Therapy, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call Dates (Business Wire)
  • U.S. Physical Therapy Announces the Acquisition of a Twelve-Clinic Physical Therapy Practice (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.8000.756-1.040222.56214.486
2026Q22026-08-050.7500.8140.253214.06211.367
2026Q12026-05-060.4600.517-0.122198.29200.947
2025Q42026-02-250.6700.675-0.438202.73199.97
2025Q32025-11-050.6600.6700.476197.13193.996
2025Q22025-08-060.8100.7150.580197.34189.666
2025Q12025-05-070.4800.4310.797183.79177.316
2024Q42025-02-260.5100.6890.524180.45174.797
2024Q32024-11-050.6900.6840.385168.03164.326
2024Q22024-08-130.7300.8190.467167.19163.346
2024Q12024-05-070.5100.5580.465155.68153.36
2023Q42024-02-280.5900.566-0.382154.8150.246
2023Q32023-11-070.6200.6170.506150.01148.856
2023Q22023-08-080.7600.7480.640151.49151.065
2023Q12023-05-030.5900.5460.576148.51140.844
2022Q42023-02-230.5800.570-0.011141.18141.094

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY2.0802.0711.761414.05409.49
2018FY2.6502.5571.311453.91453.39
2019FY2.8202.8622.451481.97481.3
2020FY2.3902.3762.476422.97421.87
2021FY3.1703.1402.415495.02493.78
2022FY2.7002.6932.254553.14553.07
2023FY2.5602.5231.279604.8600.24
2024FY2.4502.6441.841671.35665.69
2025FY2.6302.6211.420780.99778.66
2026FY-2.872--857.18
2027FY-3.356--928.69
2028FY-3.653--1,002

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-09760224.44219.34228.83
2026Q4S2026-11-05740222.39217.47228.83
2026Q4S2026-11-04720220.97217.47223
2026Q4S2026-10-27720220.97217.47223
2026Q4S2026-10-21730220.97217.47223
2026Q4S2026-10-20740220.97217.47223
2026Q4S2026-10-12750220.97217.47223
2026Q4S2026-09-14760220.97217.47223
2026Q4S2026-09-09760220.37215.32223
2026Q4S2026-08-20650219.93215.32222.39
2026Q4S2026-08-18750219.94215.32222.39
2026Q4S2026-08-13750219.98215.32222.6
2026Q4S2026-08-07740219.27215222.6
2026Q4S2026-08-06730218.5215222.6

Estimate history

EPS, annual1.7611.3112.4512.4762.4152.2541.2791.8411.422-1.3478
Period201720182019202020212022202320242025TTM
EPS, quarterly0.3850.5240.7970.580.476-0.438-0.1220.253-1.041
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual414.051453.911481.969422.969495.022553.144604.802671.345780.99837.63
Period201720182019202020212022202320242025TTM
Sales, quarterly168.033180.447183.788197.344197.132202.726198.286214.059222.558
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual12.59512.68412.77512.85212.91113.00214.98815.09415.12314.928
Period201720182019202020212022202320242025MRQ
Shares, quarterly15.07715.09415.19215.20415.20415.12315.2314.92414.928
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue837.63780.99671.35604.80553.14495.02422.97481.97453.91
Cost of Goods Sold Incl. D&A690.38624.71541.34492.82450.31384.10330.50374.71347.65
Gross Profit147.25156.28130.00111.99102.83110.9392.47107.26106.26
Selling, General and Administrative Excl. Other61.8074.3464.3742.4336.9240.2536.1339.8145.95
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income85.4581.9465.6369.5665.9170.6856.3467.4560.30
Interest Expense11.949.468.029.305.780.941.632.082.04
Unusual Expense9.60-3.412.7216.466.602.673.930.03-1.85
Net Income Before Taxes66.1377.8160.2149.3855.5773.2065.5170.9160.21
Income Taxes16.3219.8114.6112.1612.1615.2713.0213.6511.37
Consolidated Net Income68.0264.5246.8740.6944.4061.2553.7160.3855.34
Net Income From Continuing Operations-20.2221.5727.7318.1429.2631.1431.7831.2716.61
Net Income-20.2221.5727.7318.1429.2631.1431.7831.2716.61
EPS (Recurring)-0.901.261.972.092.612.562.692.451.21
EPS (Basic, Before Extraordinaries)-1.351.421.841.282.252.412.482.451.31
EPS (Diluted)-1.351.421.841.282.252.412.482.451.31
EBITDA108.27104.3384.3185.2580.6682.2766.8877.5570.06
Non-Operating Income (Expense)2.221.925.315.592.036.1214.735.560.09
Other After Tax Adjustments18.206.511.273.470.993.321.223.126.50
Stock Option Compensation Expense8.376.566.185.725.745.745.775.104.69
Price To Earnings Ratio--94.9054.4327.0639.5948.4446.6777.71
Price To Sales Ratio1.531.521.992.181.902.493.653.032.86
Gross Margin17.5820.0119.3618.5218.5922.4121.8622.2523.41
Operating Margin10.2010.499.7811.5011.9214.2813.3213.9913.29
Net Margin-2.412.764.133.005.296.297.516.493.66
Shares Outstanding14.9315.1215.0914.9913.0012.9112.8512.7712.68
Market Capitalization1,481.501,481.501,339.081,395.891,053.521,233.251,545.261,460.711,298.31

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue222.56214.06198.29202.73197.13197.34183.79180.45
Cost of Goods Sold Incl. D&A184.00175.93169.60160.86164.06159.71156.50146.07
Gross Profit38.5638.1328.6941.8733.0737.6327.2934.37
Selling, General and Administrative Excl. Other13.6014.9713.7419.4913.5913.0911.7517.42
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income24.9623.1614.9522.3819.4924.5415.5416.96
Interest Expense3.583.212.792.352.412.422.282.05
Unusual Expense0.461.512.105.53-5.18-0.06-3.70-2.75
Net Income Before Taxes21.5619.0510.5614.9622.8822.6517.3318.32
Income Taxes3.974.162.415.785.234.933.865.83
Consolidated Net Income27.1917.1010.6413.0819.6618.9512.7312.96
Net Income From Continuing Operations-15.543.81-1.84-6.647.248.8112.067.90
Net Income-15.543.81-1.84-6.647.248.8112.067.90
EPS (Recurring)-1.020.32-0.02-0.180.240.580.630.40
EPS (Basic, Before Extraordinaries)-1.040.25-0.12-0.440.480.580.800.52
EPS (Diluted)-1.040.25-0.12-0.440.480.580.800.52
EBITDA31.2129.1020.9527.0125.3230.5921.4122.64
Non-Operating Income (Expense)0.640.610.510.460.620.480.370.67
Other After Tax Adjustments9.612.202.493.902.021.23-0.740.46
Stock Option Compensation Expense2.372.501.821.671.791.671.401.57
Price To Earnings Ratio-138.2452.9632.8537.1635.9839.3194.90
Price To Sales Ratio1.531.271.431.521.701.631.571.99
Gross Margin17.3317.8114.4720.6516.7819.0714.8519.05
Operating Margin11.2210.827.5411.049.8812.438.469.40
Net Margin-6.981.78-0.93-3.283.674.476.564.38
Shares Outstanding14.9314.9215.2315.1215.2015.2015.1915.09
Market Capitalization1,481.501,045.231,133.591,187.291,291.591,187.991,099.271,339.08

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments35.5741.36152.8231.5928.5732.9223.5523.3721.93
Short Term Receivables91.4486.5771.8269.3163.0251.6558.8553.6952.56
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets12.989.658.7310.373.583.072.992.152.59
Total Current Assets139.99137.58233.38111.2795.1787.6485.3979.2177.08
Net Property, Plant & Equipment179.85166.08129.53127.75119.41103.26103.6820.1720.39
Total Investments and Advances12.4514.2014.9214.6512.210.000.000.000.00
Intangible Assets865.25846.46619.25602.86521.06401.93370.26342.35320.29
Deferred Tax Assets32.8239.3230.8530.5930.2526.6424.762.482.06
Other Assets6.473.150.161.631.581.541.521.431.22
Total Assets1,236.831,206.791,028.08888.75779.67621.00585.61445.64421.04
Short Term Debt Incl. Current Port. of LT Debt52.0050.8342.9441.5731.3032.4127.211.434.04
Accounts Payable6.065.943.906.506.471.332.492.022.17
Income Tax Payable-----5.71-0.002.83
Other Current Liabilities80.9859.5155.3437.4145.7054.0330.8638.4930.51
Total Current Liabilities139.04116.28102.1985.4983.4893.4960.5641.9539.55
Long Term Debt263.17244.40215.64253.76191.7778.58110.6238.4056.73
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities61.2168.7955.6651.9044.6334.4234.8311.4912.94
Other Liabilities3.2118.272.3613.037.344.540.142.992.86
Total Liabilities466.63447.74375.85404.18327.23211.03206.1694.82112.07
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity476.43488.93476.19315.79295.61276.16240.26215.94204.87
Total Shareholders Equity476.43488.93476.19315.79295.61276.16240.26215.94204.87
Accumulated Minority Interest293.77270.12176.04168.78156.84133.81139.19134.87104.10
Total Equity770.20759.05652.24484.57452.44409.97379.45350.82308.97
Total Liabilities & Stockholders Equity1,236.831,206.791,028.08888.75779.67621.00585.61445.64421.04
Book Value Per Share31.5032.3931.7724.2922.8921.4918.8117.0216.27
Tangible Book Value Per Share-25.71-23.69-9.55-22.08-17.46-9.79-10.18-9.97-9.16
Full-Time Employees7,2947,0286,7206,1355,5004,6305,4004,6004,300
Price to Book Ratio3.452.772.843.324.175.606.086.014.58
Return on Assets1.772.481.893.514.455.276.063.835.71
Return on Equity4.475.754.589.5710.8912.3113.717.8911.28
Return on Invested Capital2.923.782.625.146.398.968.916.538.46
Quick Ratio1.011.182.281.301.140.941.411.891.95
Current Ratio1.011.182.281.301.140.941.411.891.95

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income49.8158.0145.6037.2243.4157.9252.4957.2648.84
Depreciation22.8222.3918.6815.7014.7411.5910.5310.109.76
Other Funds (Non Cash)27.8911.8618.7830.3318.7713.0813.596.428.86
Funds from Operations108.50103.6688.4287.7481.2388.2876.3678.4372.27
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-18.31-27.19-12.40-4.93-21.43-11.7223.64-15.980.73
Cash from Operating Activities90.1976.4776.0282.8159.8076.56100.0062.4573.00
Capital Expenditures-19.74-14.07-9.19-9.29-8.25-8.20-7.64-10.19-7.19
Net Assets From Acquisitions-60.91-25.86-142.14-37.85-75.06-116.56-44.53-39.68-16.98
Sale of Fixed Assets and Businesses0.330.220.100.980.400.200.970.270.00
Purchase or Sale of Investments0.000.700.000.000.370.280.0011.600.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.700.000.000.370.280.0011.600.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.830.900.690.320.000.000.000.000.00
Cash from Investing Activities-79.49-38.12-150.53-45.84-82.53-124.29-51.20-37.99-24.17
Cash Dividends Paid-27.58-27.36-26.54-24.13-21.32-18.77-4.11-14.55-11.66
Change in Capital Stock-24.80-5.570.00163.650.000.000.000.000.00
Repurchase of Common Pref Stock-24.80-5.570.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.00163.650.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.00163.650.000.000.000.000.00
Issuance or Reduction of Debt, Net84.028.064.30-39.1562.4293.10-31.046.57-20.04
Change in Long Term Debt84.028.064.30-39.1562.4293.10-31.046.57-20.04
Issuance of Long Term Debt320.67189.5019.0024.00249.22316.00214.00145.00103.00
Reduction of Long Term Debt-236.65-181.44-14.70-63.15-186.81-222.90-245.04-138.43-123.04
Net Financing Active Other Cash Flow-35.23-19.27-14.71-16.10-15.34-30.96-4.28-16.29-15.69
Other Financing Activities Uses-35.22-19.27-14.71-16.10-15.35-30.98-18.33-16.29-15.69
Cash from Financing Activities-3.58-44.14-36.9584.2725.7643.38-39.42-24.27-47.40
Net Change in Cash7.12-5.79-111.46121.233.03-4.359.370.181.44
Free Cash Flow70.4662.4066.8373.5151.5568.3692.3652.2665.81
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow29.8533.8233.1626.7634.8124.8517.4938.6923.94
Deferred Taxes & Investment Tax Credit-11.415.374.494.315.69-0.264.654.81

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments38.2324.8928.4435.5731.1034.09
Short Term Receivables97.3998.1696.7291.4491.3093.39
Inventories0.000.000.000.000.000.00
Other Current Assets19.1516.6313.9512.9816.0313.06
Total Current Assets154.76139.68139.11139.99138.44140.53
Net Property, Plant & Equipment206.57196.90187.82179.85174.15169.37
Total Investments and Advances13.4912.7112.6712.4512.5512.63
Intangible Assets913.18893.08895.69865.25866.84853.22
Deferred Tax Assets---32.82--
Other Assets7.746.506.766.474.303.85
Total Assets1,295.741,248.871,242.061,236.831,196.271,179.60
Short Term Debt Incl. Current Port. of LT Debt48.9747.4353.5852.0050.7649.21
Accounts Payable5.366.926.766.067.424.20
Income Tax Payable0.000.00----
Other Current Liabilities54.8955.5656.9680.9856.9065.44
Total Current Liabilities109.22109.91117.30139.04115.08118.84
Long Term Debt370.97338.36309.25263.17257.64256.19
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities23.9331.0030.7761.2135.7034.40
Other Liabilities4.242.951.863.215.414.57
Total Liabilities508.36482.22459.19466.63413.83414.01
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity429.30448.66468.98476.43503.57500.75
Total Shareholders Equity429.30448.66468.98476.43503.57500.75
Accumulated Minority Interest358.08318.00313.90293.77278.88264.84
Total Equity787.38766.66782.87770.20782.44765.59
Total Liabilities & Stockholders Equity1,295.741,248.871,242.061,236.831,196.271,179.60
Book Value Per Share28.7630.0630.7931.5033.1232.94
Tangible Book Value Per Share-32.41-29.78-28.02-25.71-23.89-23.18
Full-Time Employees---7,294--
Price to Book Ratio3.452.232.382.362.582.39
Return on Assets-1.620.210.631.763.243.14
Return on Equity-4.330.541.574.457.307.02
Return on Invested Capital-1.940.48-0.24-0.900.951.16
Quick Ratio1.421.271.191.011.201.18
Current Ratio1.421.271.191.011.201.18

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income17.5914.908.169.1817.6417.72
Depreciation6.255.936.004.635.836.06
Other Funds (Non Cash)6.226.615.989.08-0.724.16
Funds from Operations32.5629.3923.4323.1326.6429.97
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-6.135.12-19.432.12-6.275.25
Cash from Operating Activities26.4334.514.0025.2520.3635.22
Capital Expenditures-5.07-5.36-5.37-3.93-4.32-3.25
Net Assets From Acquisitions-22.40-1.35-35.29-1.88-8.52-10.35
Sale of Fixed Assets and Businesses-0.010.330.34-0.330.170.35
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.30-0.160.320.360.300.18
Cash from Investing Activities-27.18-6.55-40.00-5.77-12.36-13.06
Cash Dividends Paid-6.86-13.870.00-6.84-6.84-13.68
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.00-19.230.00-5.570.000.00
Repurchase of Common Pref Stock0.00-19.230.00-5.570.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net25.5514.8741.552.05-0.24-6.53
Change in Long Term Debt25.5514.8741.552.05-0.24-6.53
Issuance of Long Term Debt81.00119.6777.0043.0073.0056.50
Reduction of Long Term Debt-55.45-104.80-35.45-40.95-73.24-63.03
Net Financing Active Other Cash Flow-4.59-13.28-12.69-4.67-3.91-7.04
Other Financing Activities Uses-4.59-13.28-12.69-4.66-3.91-7.04
Cash from Financing Activities14.09-31.5228.86-15.02-10.99-27.25
Net Change in Cash13.34-3.55-7.134.47-2.98-5.10
Free Cash Flow21.3529.15-1.3721.3316.0531.96
Price to Free Cash Flow29.8527.5328.0033.8041.5733.83

Revenue breakdown

Net Patient Revenues2024: 560.55M 2025: 650.43M
Other Revenues2024: 110.79M 2025: 130.56M
United States2024: 671.35M 2025: 780.99M
Industrial Injury Prevention Services Revenues2024: 96.91M 2025: 114.40M
Physical Therapy Operations2024: 574.43M 2025: 666.59M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.77%1.1M14.5M184.55K
2026-10-158.22%1.2M14.5M201.38K
2026-09-308.94%1.3M14.5M208.51K
2026-09-158.90%1.3M14.5M214.93K
2026-08-318.83%1.3M14.6M220.02K
2026-08-148.73%1.3M14.6M233.45K
2026-07-317.45%1.1M14.8M241.72K
2026-07-156.84%1.0M14.8M223.10K
2026-06-307.13%1.1M14.8M208.41K
2026-06-157.42%1.1M14.8M198.26K
2026-05-297.03%1.0M14.8M195.90K
2026-05-156.26%0.9M14.8M197.22K
2026-04-306.83%1.0M14.8M184.04K
2026-04-156.69%1.0M14.8M191.27K
2026-03-316.96%1.0M14.8M207.98K
2026-03-137.33%1.1M14.8M207.58K
2026-02-276.84%1.0M14.8M202.08K
2026-02-136.35%0.9M14.9M202.57K
2026-01-305.96%0.9M14.9M196.76K
2026-01-156.09%0.9M14.9M184.59K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call40.0058.4061.100.003.7540.000.000.985-0.1000.006
call45.0053.0056.300.003.5010.000.000.982-0.0990.007
call50.0048.7051.100.003.0790.000.000.980-0.0980.007
call55.0043.7046.100.002.7150.000.000.977-0.0960.008
call60.0038.0041.100.002.3930.000.000.974-0.0940.009
call65.0033.4036.100.001.9520.000.000.970-0.0920.010
call70.0028.4030.900.001.5730.000.000.966-0.0900.012
call75.0023.4026.000.001.4000.000.000.960-0.0860.014
call80.0018.8020.900.001.1850.000.000.951-0.0820.016
call85.0013.8015.906.200.9256000.000.939-0.0770.019
call90.008.7010.806.500.5965.000.000.761-0.3010.049
call95.003.506.301.700.5271,0000.000.687-0.2380.056
call1001.504.600.000.7210.000.000.530-0.2670.062
call1050.054.000.000.9620.000.000.396-0.3120.061
call1100.003.600.001.1390.000.000.334-0.3630.057
call1150.003.300.001.3160.000.000.284-0.3910.053
call1200.003.100.001.4740.000.000.251-0.4110.050
put40.000.002.600.003.0210.000.00-0.015-0.1000.006
put45.000.002.600.002.6650.000.00-0.017-0.0990.007
put50.000.002.600.002.3560.000.00-0.019-0.0970.007
put55.000.002.600.002.0670.000.00-0.022-0.0950.008
put60.000.002.600.001.7970.000.00-0.025-0.0930.009
put65.000.002.600.001.5520.000.00-0.029-0.0900.010
put70.000.002.600.001.3280.000.00-0.034-0.0870.012
put75.000.002.601.301.1114.000.00-0.040-0.0830.014
put80.000.002.600.000.9040.000.00-0.048-0.0790.016
put85.000.000.300.050.6931500.00-0.061-0.0730.019
put90.000.002.650.001.0990.000.00-0.239-0.2960.049
put95.000.003.000.000.8520.000.00-0.307-0.2330.055
put1001.554.903.400.8003.000.00-0.469-0.2610.062
put1055.508.000.000.7950.000.00-0.604-0.3050.060
put1109.5012.500.000.9540.000.00-0.668-0.3590.057
put11514.0017.500.001.2070.000.00-0.714-0.3820.053
put12019.4022.500.001.3510.000.00-0.749-0.4010.050

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-098-KCurrent report2026-11-05SEC
2026-11-068-KCurrent report2026-11-04SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-30SCHEDULE 13G/ASEC
2026-10-13SCHEDULE 13GSEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-013Initial statement of beneficial ownership of securities2026-10-01SEC
2026-09-288-KCurrent report2026-09-22SEC
2026-09-218-KCurrent report2026-09-15SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-06-12SEC
2026-09-023Initial statement of beneficial ownership of securities2026-09-01SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-148-KCurrent report2026-08-12SEC
2026-08-13SCHEDULE 13G/ASEC
2026-08-12SCHEDULE 13G/ASEC
2026-08-128-KCurrent report2026-08-12SEC
2026-08-108-KCurrent report2026-08-06SEC
2026-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-05SEC
2026-08-04SCHEDULE 13G/ASEC
2026-07-068-KCurrent report2026-07-01SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-08SEC
2026-05-284/A2026-05-19SEC
2026-05-284/A2026-05-19SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-09416100
2026-080000
2026-070000
2026-0648.83K300
2026-050000
2026-040000
2026-0300297.13K2
2026-020000
2026-010000
2025-120000
2025-11276.00K152.76K1

Institutional holders

Manager% owned
BlackRock, Inc.14.88%
Copeland Capital Management, LLC6.30%
Bahl & Gaynor LLC5.96%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC5.56%
STATE STREET CORP4.65%
MORGAN STANLEY4.59%
VANGUARD CAPITAL MANAGEMENT LLC4.43%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC4.42%
Neuberger Berman Group LLC3.94%
AMERICAN CENTURY COMPANIES INC3.67%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF6.03%
Bahl & Gaynor Small/Mid Cap Income Growth ETF3.82%
Neuberger Genesis Fund3.27%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.18%
Small Cap Growth Fund2.79%
iShares Russell 2000 ETF2.60%
Virtus KAR Small-Cap Growth Fund2.59%
Fidelity Small Cap Value Fund2.18%
Calvert Small Cap Fund1.95%
SouthernSun Small Cap Fund1.16%

OakChart. USPH. Cached 15 minutes.